Bromide

Bromide

SCHEMBL3701110

Br.NCCNC(N)=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1155049 0.97
Hydrochloric Acid SCHEMBL12469892 0.94
SCHEMBL29270038 0.81 CA5B (0.55)
SCHEMBL11515499 0.81 CA5B (0.55)
SCHEMBL175234 0.81 TDP1 (0.46)
SCHEMBL3406422 0.80
SCHEMBL1332569 0.78
Monoethanolamine SCHEMBL6872043 0.78 ALDH1A1 (0.42)
SCHEMBL3281043 0.77
SCHEMBL627424 0.76 PAOX (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603468-B2 Neutralization of HCV THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-12-10 US disclosed
US-20100247522-A1 LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS THE GOV. OF THE U.S.A AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVICES 2010-09-30 US disclosed
WO-2009061739-A1 NEUTRALIZATION OF HCV THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2009-05-14 WO disclosed
EP-0509656-B1 Compositions of phytosterols and phytosterolins as immunmodulators ROOPEROL NA NV (NL) 1996-09-18 EP disclosed
US-5486510-A Method and compositions for modulating or control of immune responses in humans ROOPEROL (NA) NV (NL) 1996-01-23 US disclosed
EP-0141783-B2 IMMUNE RESPONSE TO TUMOURS AND VIRUSES INDUCED BY ANTI-IDIOTYPE ANTIBODIES THE WISTAR INSTITUTE (US) 1993-06-16 EP disclosed
EP-0509656-A1 Compositions of phytosterols and phytosterolins as immunmodulators ROOPEROL (NA) NV (NL) 1992-10-21 EP disclosed
US-5053224-A Induction of antibody response to solid tumors with anti-idiotype antibodies KOPROWSKI HILARY (US) 1991-10-01 US disclosed
EP-0141783-B1 IMMUNE RESPONSE TO TUMOURS AND VIRUSES INDUCED BY ANTI-IDIOTYPE ANTIBODIES THE WISTAR INSTITUTE (US) 1989-08-09 EP disclosed
WO-1985002121-A1 IMMUNE RESPONSE TO TUMORS AND VIRUSES INDUCED BY ANTI-IDIOTYPE ANTIBODIES THE WISTAR INSTITUTE (US) 1985-05-23 WO disclosed
EP-0141783-A2 Immune response to tumours and viruses induced by anti-idiotype antibodies THE WISTAR INSTITUTE (US) 1985-05-15 EP disclosed